Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Techniclone (TCLN) -- Ignore unavailable to you. Want to Upgrade?

To: EZLibra who wrote (963)	12/30/1997 8:33:00 PM
From: Dave Belz	Read Replies (1) \| Respond to of 3702

Davis Thanks for the informative posts. Its nice to see some substance on the board other than bantering back and forth. Not to start anything, but it was refreshing to read what you posted. Yes, I have heard that one individual has favored a short position for the stock maybe because it would hurt some of the current management team. I would not support that as a reason and certainly cant verify that it is true. However, there are many people that are tired, frustrated, angry, etc. over the turn of events in the last year. But alas, it is the eve of a new year and with that a new reason for hope. I bought some more stock today. Dont tell my wife!! You have to have some nerve, but if you believe then you either turn out to be brilliant or a fool. Nothing boring about it. Pure energy and thats biotechs. Why are the rest of you still in this stock? I know of no one who has sold the stock. All my friends, relatives and other acquaintences are still in the stock. Some have bought more. My question - who is selling?

To: EZLibra who wrote (963)	12/31/1997 1:41:00 AM
From: Maurice Winn	Read Replies (1) \| Respond to of 3702

Davis, this guy, thorn though he may be, can't decide the price of the shares other than by buying or selling. If he sells, to try to force the price down, to punish his nemesis, then that is called cutting off your nose to spite your face. Such a person will find they own no shares, having sold them at a discount to real value and the share price, after they are cleaned out, will rise. If he buys, to force the price up, then once he is sated, out of money or the price is too high and he gives up, then the price will fall again until buyers and sellers are in balance. As you can see, I don't put much store in that concept. I think the price is more to do with a lack of confidence by the broader investing world in Techniclone's overall position. Of course management issues are part of that. I've read some of the home page thanks, more to go. Lots more. Yes, I'm in NZ, which is where I'm from and where I live. Techniclone has competitors in Bexxar, Rituxan, Y2B2, anti- angiogenesis and others. I131 treatments seem common. The TNT and other treatments are a bit distant still and the main test of the company seems likely to be its management of and success in I131 treatment of NHL. I won't ask you to repeat what is probably waiting for me to read elsewhere, but the important issue [apart from internecine warfare] seems to be the competitive position of Oncolym. Antiangiogenesis to kill off larger tumors then Rituxan or similar non-radioactive monoclonal antibodies seems a cleaner and more effective way of curing Non-Hodgkins Lymphoma. I realize those treatments are not available yet, but the prospect limits the money making period for I131 treatments. Maybe only 5 years. Incidentally, I've previously been in discussions in communications about cellphones and brain cancer. To be talking about hundreds of millions of times the amount of radiation which people endure from cellphones seems incongruous. Customer resistance to radiation and the leukemias and other cancers which result would be significant. People don't like to see the doctors dressed up in massively protective gear and the stuff goes right into your veins! I remain to be convinced that I131 in general and Techniclone's in particular is the real oil. For more than a few years. It beats cyclophosphamide, vincristine, adriamycin and prednisone with bulk untargetted radiation though. Good luck to Techniclone, I need it. Maurice